Skip to content
Home/Companies/Biotech/Abolis Biotechnologies

Abolis Biotechnologies

Biotech·France·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Abolis Biotechnologies?

Abolis Biotechnologies is currently owned by DeepTech & Climate Fonds through DeepTech & Climate Fonds (2022 vintage), since 2024.

Hand-verified · updated 2026-07-03

DeepTech & Climate Fonds
Investor
DeepTech & Climate Fonds
DeepTech & Climate Fonds · 2022 · Evergreen

Key facts

HQFrance
SectorBiotech
StatusActive

More from DeepTech & Climate Fonds

Other portfolio companies in the same fund.

Stenon
Stenon
Active
SoftwareGermany· 2026
Synera
Synera
Active
SaaSGermany· 2026
UniverCell
UniverCell
Active
ClimateTechGermany· 2026
Clinomic
Clinomic
Active
MedTechGermany· 2025
Genomines
Genomines
Active
IndustrialsFrance· 2025
Hypatos
Active
SoftwareGermany· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Abolis Biotechnologies

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Abolis Biotechnologies?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Abolis Biotechnologies.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue